US Patent 7906146 Lyophilized formulations of exendins and exendin agonist analogs
Patent 7906146 was granted and assigned to Amylin Pharmaceuticals on March, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 27 Nov, 2023
Golden AI
Edits made to:
Article (+108 characters)
Article
Patent abstract
Novel formulations containing exendins, exendin agonists and/or exendin analogs are provided.
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Andrew A. Young0
James J. L'Italien0
Orville G. Kolterman0
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07906146 Lyophilized formulations of exendins and exendin agonist analogs US Patent 7906146 Lyophilized formulations of exendins and exendin agonist analogs
Infobox
Patent Number
079061460
Patent Number
79061460
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 7 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079061460
Date of Patent
March 15, 2011
0Patent Application Number
123895090
Date Filed
February 20, 2009
0Official Website
Patent Primary Examiner
Edits on 4 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 7 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07906146 Lyophilized formulations of exendins and exendin agonist analogs
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07906146
Date of patent
March 15, 2011
Patent application number
12389509
Date Filed
February 20, 2009
Patent primary examiner
Find more entities like US Patent 7906146 Lyophilized formulations of exendins and exendin agonist analogs
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
